Ablacon

About:

Ablacon is a provider of AI-guided atrial fibrillation therapies.

Top Investors: Ajax Health, Western Technology Investment, Zeus Health

Description:

Ablacon has built a premier machine intelligence system to quantitatively and qualitatively understand and treat atrial fibrillation (AF).Their technology visualizes in real-time what is going on in the heart. They compute the electrographic flow which allows to treat atrial fibrillation faster, more precisely and more reliably.

Total Funding Amount:

$63.5M

Headquarters Location:

Wheat Ridge, Colorado, United States

Founded Date:

2015-01-01

Contact Email:

contact(AT)ablacon.com

Founders:

Peter Ruppersberg, Philip Haeusser

Number of Employees:

11-50